UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015205
Receipt number R000017322
Scientific Title The clinical study for the joint treatment by allogeneic cell sheet
Date of disclosure of the study information 2014/10/01
Last modified on 2022/03/29 12:13:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical study for the joint treatment by allogeneic cell sheet

Acronym

The clinical study for the joint treatment by allogeneic cell sheet

Scientific Title

The clinical study for the joint treatment by allogeneic cell sheet

Scientific Title:Acronym

The clinical study for the joint treatment by allogeneic cell sheet

Region

Japan


Condition

Condition

Cartilage defects associated with osteoarthritis of the knee

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Chondrocytes isolated from samples obtained at polydactyly surgery are passaged in culture as allogeneic cells and then cryopreserved. From the cryopreserved samples, cells which have been verified for safety and property checked as chondrocyte sheet are cultured and fabricated into an allogeneic chondrocyte sheet. The sheet is then transplanted into patient with cartilage defect of the knee joint, and cartilage regeneration is evaluated. We provide objective evaluations of the safety of this new treatment as a primary endpoint.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frequency and content of adverse events.

Key secondary outcomes

Clinical evaluation, X-ray, MRl, Arthroscopy, Photoacoustic evaluation, and Pathological evaluation.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Chondrocytes isolated from samples obtained at polydactyly surgery are passaged in culture as allogeneic cells and then cryopreserved. From the cryopreserved samples, cells which have been verified for safety and property checked as chondrocyte sheet are cultured and fabricated into an allogeneic chondrocyte sheet. The sheet is then transplanted into patient with cartilage defect of the knee joint.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Cartilage defects under arthroscopy must be greater than or equal to Outerbridge classification Grade III. In addition, the patellofemoral joint and/or the condyle of the femur must have a cartilage defect or defects which can be fully covered by allogeneic chondrocyte sheets and which have traditionally been indicated for marrow stimulation techniques or osteochondral autografts.

Key exclusion criteria

1. Obtaining informed consent from the patient is difficult.
2. Having complications hindering surgery under general anesthesia or complications affecting knee surgery.
3. Having problematic infectious disease (including positive of HBV, HCV, HIV, HTLV, FTA-ABS.)
4. Having rheumatoid arthritis or other systemic inflammatory disease.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Sato

Organization

Tokai University School of Medicine

Division name

Surgical Science, Department of Orthopaedic Surgery

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa

TEL

0463-93-1121

Email

sato-m@is.icc.u-tokai.ac.jp


Public contact

Name of contact person

1st name Masato
Middle name
Last name Sato

Organization

Tokai University School of Medicine

Division name

Surgical Science, Department of Orthopaedic Surgery

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa

TEL

0463-93-1121

Homepage URL


Email

sato-m@is.icc.u-tokai.ac.jp


Sponsor or person

Institute

Tokai University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokai university certified committee for regenerative medicine

Address

143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan

Tel

0463-93-1121

Email

watanabe@tsc.u-tokai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 05 Month 19 Day

Date of IRB

2016 Year 03 Month 11 Day

Anticipated trial start date

2016 Year 12 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 09 Month 19 Day

Last modified on

2022 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017322


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name